Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

Trials and registries - Long term clinical outcomes after TAVI

21 May 2019 – From EuroPCR 2019

Consult this session to learn about the latest trials and registries regarding the long term clinical outcomes after TAVI, such as CHOICE, INTeNSE, RASTAVI, and more!

Trials and registries

The aortic stenosis spectrum in 2019: limiting TAVI related complications and promoting early discharge

21 May 2019 – From EuroPCR 2019

Consult this session on the aortic stenosis spectrum in 2019 to learn all about how to limit TAVI related complications (such as paravalvular leakage) while choosing the appropriate device, and how to promote early discharge with simplified TAVI.

The aortic stenosis spectrum in 2019: limiting TAVI related complications and promoting early discharge

Cerebrovascular event after TAVI - predictors and prevention

21 May 2019 – From EuroPCR 2019

Consult this session to discover various studies and meta-analysis related to cerebrovascular event after TAVI, and learn more about how to predict and prevent it.

Cerebrovascular event after TAVI - predictors and prevention

Will the PARTNER 3 Low Risk trial change my practice?

21 May 2019 – From EuroPCR 2019

Consult this session to learn more about the relevance of the PARTNER 3 Low Risk TAVI trial, how the results apply to specific patients and how they may impact your clinical practice.

Will the PARTNER 3 Low Risk trial change my practice?

Bicuspid aortic stenosis: from imaging to TAVI

21 May 2019 – From EuroPCR 2019

Consult this session on bicuspid aortic stenosis to learn more about the roles of imaging and TAVI to treat it, from implantation to clinical outcomes, thanks to a selection of compelling cases and studies.

Bicuspid aortic stenosis: from imaging to TAVI

Valve-in-valve intervention in small surgical bioprostheses

21 May 2019 – From EuroPCR 2019

Consult this session on valve-in-valve interventions in small surgical bioprostheses to discover challenging cases: controlled fracture of a Mitroflow aortic bioprosthesis during ACURATE neo valve-in-valve procedure, combined valve-in-valve implantation and double-chimney technique PCI, and more!

Valve-in-valve intervention in small surgical bioprostheses

Valve-in-valve: not that simple after all!

21 May 2019 – From EuroPCR 2019

Consult this session to discover complex TAVI clinical cases, and find out about innovative treatment options, how to assess the risks of this procedure and how to tackle potential complications.

Valve-in-valve: not that simple after all!

PCR's Got Talent - Round 1 - Session 1

21 May 2019 – From EuroPCR 2019

Consult this session to discover the abstracts submitted by young practitioners during the 1st round of PCR's Got Talent, and presented live during EuroPCR 2019 abstract competition.

PCR's Got Talent - Round 1 - Session 1

PCR's Got Talent - Round 1 - Session 2

21 May 2019 – From EuroPCR 2019

Consult this session to discover the compelling abstracts submitted during the 1st round of PCR's Got Talent, and presented on-stage during EuroPCR 2019 abstract competition.

PCR's Got Talent - Round 1 - Session 2

Cases you will see only once...

21 May 2019 – From EuroPCR 2019

Consult this session to discover various unusual cases and complications: pathological anatomy of heart with late-contained aortic root rupture, aorta right ventricular fistula after TAVI, painless paraplegia after TAVI, and more!

Cases you will see only once...

PCR STATEMENT on evolving indications for transcatheter aortic valve implantation

21 May 2019

Paris, France, 21 May 2019. Severe symptomatic aortic stenosis, a degenerative disease-causing calcification and immobility of the aortic valve leaflets leading to left ventricular outflow obstruction, is the most common valve lesion leading to intervention in Europe and the USA. Symptoms include heart failure, syncope and...

Evolving indications for transcatheter aortic valve implantation

Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years

28 Mar 2019

A study to determine the long-term outcomes of high-risk patients who underwent transcatheter aortic valve implantation with the third-generation CoreValve device, according to the 2017 EAPCI/ESC/EACTS definition of valve durability.

Authors :

R. Antonazzo Panico, C. Giannini, M. De Carlo, M. Angelillis, P. Spontoni, A. Pieroni, G. Costa, P. Bertini, F. Guarracino, A. Sonia Petronio
EuroIntervention: long-term outcomes and durability of TAVI

Vascular access during TAVI

25 Mar 2019

Find out more about access: fluoroscopy guided access, echo-guided access, femoral angiography, straightening femoral trajectory with a stiff guidewire, preclosure...

Procedural concepts: vascular access

Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients (PARTNER 3 Trial)

17 Mar 2019

Elad Asher

Reviewer

Elad Asher

Reviewer

Salvatore Brugaletta
Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients (PARTNER 3 Trial)

ACC 2019 Day 1: PARTNER 3, Evolut Low Risk Trial and Apple Heart Study

17 Mar 2019

Mirvat Al Asnag reports live on three late-breaking trials presented at ACC 2019: PARTNER 3, Evolut Low Risk Trial and the Apple Heart Study

Live from ACC 2019 Day 1: PARTNER 3, Evolut Low Risk Trial and Apple Heart Study

PCR @ ACC 2019 Scientific Sessions

13 Mar 2019

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2019 Scientific Sessions #ACC19.

PCR @ ACC.19 Scientific Sessions

Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk

05 Mar 2019

The NOTION trial is among the first to provide comparative data regarding bioprosthetic valve durability for TAVR and SAVR from a randomised clinical trial in patients with low surgical risk for mortality.

Erik Walter Holy

Reviewer

Erik Walter Holy

Reviewer

Salvatore Brugaletta
Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk

Long-term durability of transcatheter aortic valve prostheses

27 Feb 2019

This joint review is part of the PCRonline GLOBAL Journal Club Initiative by selected members of the EAPCI/PCR Journal Club and PCR NextGen, and is based on the underlying idea of “Bringing peers together, exchanging ideas, towards a common standard of care”.

Elad Asher

Reviewer

Elad Asher

Reviewer

Salvatore Brugaletta
Long-term durability of transcatheter aortic valve prostheses

Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement

22 Feb 2019

This joint review is part of the PCRonline GLOBAL Journal Club Initiative by selected members of the EAPCI/PCR Journal Club and PCR NextGen, and is based on the underlying idea of “Bringing peers together, exchanging ideas, towards a common standard of care”.

Luigi Biasco

Reviewer

Luigi Biasco

Reviewer

Christopher Cook
Prosthesis-patient mismatch in patients undergoing transcatheter aortic valve replacement

First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system

21 Feb 2019

The J-Valve transcatheter aortic valve consists of the valve and three U-shaped “anchor rings” and is deployed in a two-step process.

Authors :

M. Hensey, D. J. Murdoch, J. Sathananthan, A. Alenezi, G. Sathananthan, R. Moss, P. Blanke, J. Leipsic, D. A. Wood, A. Cheung, J. Ye, J. G. Webb
EuroIntervention: First-in-human TF J-Valve system